These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 23657189

  • 1. India remains on US trade "priority watch list" for failing to uphold international drug company patents.
    Arie S.
    BMJ; 2013 May 08; 346():f2949. PubMed ID: 23657189
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN, Shadlen KC, Amin TM.
    Science; 2012 Jul 27; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Patents: a threat to innovation?
    Manocaran M.
    Science; 2010 Jan 01; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Maximizing exclusivity for drug products.
    French H.
    Nat Rev Drug Discov; 2005 Sep 01; 4(9):709. PubMed ID: 16178117
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E.
    Chic J Int Law; 2002 Sep 01; 3(1):27-46. PubMed ID: 15709298
    [No Abstract] [Full Text] [Related]

  • 15. Should the patent system for new medicines be abolished?
    DiMasi JA, Grabowski HG.
    Clin Pharmacol Ther; 2007 Nov 01; 82(5):488-90. PubMed ID: 17952100
    [No Abstract] [Full Text] [Related]

  • 16. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
    Baker BK.
    PLoS Med; 2016 Mar 01; 13(3):e1001970. PubMed ID: 26954325
    [Abstract] [Full Text] [Related]

  • 17. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM.
    Am J Law Med; 2001 Mar 01; 27(4):469-85. PubMed ID: 11837145
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO.
    Chic J Int Law; 2002 Mar 01; 3(1):47-68. PubMed ID: 15709299
    [No Abstract] [Full Text] [Related]

  • 20. Pharmaceuticals and medical devices: business practices. Issue brief.
    Steiner DJ.
    Issue Brief Health Policy Track Serv; 2012 Dec 31; ():1-36. PubMed ID: 23297448
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.